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Introduction

74
Fertility is restored within a few months following kidney transplantation. 75
Approximately 2% of female kidney transplant recipients of childbearing age 76 become pregnant(1). Published data on pregnancy outcomes after kidney 77 transplantation derive from self-reporting registries and single-centre 78 studies(2-6). Transplant function(3, 5, 7), pre-existing hypertension(5), and 79 time since transplantation(2, 7, 8) may predict risk to the mother, kidney and 80 fetus. Data on transplant and maternal survival suggest that live birth does not 81 adversely affect patient or allograft survival(4) but these are limited by patient 82 overlap (in registries), classification differences, reporting biases or single-83 centre studies with short follow-up and no adequate control group. 84
This study aimed to examine obstetric and kidney outcomes in women with 85 kidney transplants, investigate changes in outcomes over four decades and 86 explore factors influencing obstetric and kidney outcomes. We compared 87 maternal and transplant outcomes in pregnancy to matched patients, who did 88 not become pregnant over this period. 89
90
Patients and Methods
91
Study population and baseline data 92
This was a single-centre retrospective cohort study from Glasgow Transplant 93
Unit, where almost 3000 adult renal transplants have been performed 94 between 1970 and 2014 with a prevalent transplant population of 95 approximately 900 adults at December 2014. 96
All women reporting a pregnancy between January 1st, 1973 and February 97 28th, 2013 whilst having a functioning kidney transplant were identified from 98 the electronic patient record. Those requiring temporary dialysis during 99 pregnancy or returning to long-term dialysis shortly before delivery were 100 included. All women delivered at three different obstetric units across the 101 region. Two investigators (SS, MG) extracted the information needed 102 independently using a data collection form. 103
The following characteristics were recorded: age, ethnicity, weight, previous 104 pregnancies, last menstrual period, delivery date, clinic blood pressure (BP), 105 cause of established renal failure (ERF), time on renal replacement therapy 106 (RRT), prior kidney transplant, decade of transplantation, time since 107 transplant, transplant source (deceased or live donation), prior acute rejection, 108 pre-and post-pregnancy serum creatinine and urinary protein quantification. 109
Maintenance immunosuppression regimen used prior to and during 110 pregnancy was recorded. 111
Outcome data were gestational age, birth weight, pregnancy outcome, 112 obstetric complications (gestational hypertension, preeclampsia and 113 caesarean section), neonatal survival (>28 days), and presence of congenital 114 anomaly. Transplant outcomes were acute rejection during pregnancy, 115 transplant loss during pregnancy and within two years post-partum, and 116 deterioration of renal function associated with pregnancy. Patient and 117 transplant outcomes were analysed from time of delivery. 118
We analysed obstetric outcomes in two subgroups of patients according to 119 estimated glomerular filtration rate (eGFR) (≤ or >45ml/min/1.73m 2 ) assuming 120 that women with normal or mildly impaired renal function have better 121
outcomes. The cut-off was selected as being consistent with the KDIGO 122 classification of Stage 3a and 3b chronic kidney disease (CKD) and was felt to 123 be clinically meaningful. 124
Estimated glomerular filtration rate was calculated using the Modification of 125 Diet in Renal Disease formula(9). Urine protein:creatinine ratio (uPCR) was 126 used as an estimation of proteinuria. If no uPCR value was available, 24-hour 127 urine protein excretion was used, dividing the value in mg by 10 to achieve 128 equivalent in mg/mmol(10). Small for gestational age was calculated from 129 birth weight compared to UK references(11). 130
131
Outcome definitions 132
Pregnancy outcomes were live birth, miscarriage (<20 weeks gestation), 133 termination, ectopic pregnancy and stillbirth (≥20 weeks gestation)(12). 
Case-cohort study 151
Long-term transplant and maternal survival rates were compared to a control 152 cohort of non-pregnant renal transplant recipients using matched survival 153
analyses. The electronic patient record, case notes and clinic letters were 154 viewed to ensure that the non-pregnant controls did not become pregnant 155 over the study period. Non-pregnant women receiving a kidney transplant 156 matched for age (±5 years), transplant vintage (±10 years) and serum 157 creatinine (±30mmol/L or 0.34mg/dL) were chosen as controls whilst blinded 158 for outcomes. To match the age of the graft at conception for non-pregnant 159 women, transplantation to pregnancy interval was calculated for each 160 pregnant woman to define a 'matching day' and to assign a 'pre-pregnancy 161 eGFR' in each control. For comparisons between groups, the 'matching day' 162 in controls and the last menstrual period day in pregnant renal allograft 163 recipients were used. Once the match was made, pregnancy to delivery 164 interval was used to define a 'simulated delivery day' and to calculate 165 'gestational period' in control subjects. Serum creatinine was retrieved at 1, 5 166 and 10 years after 'delivery day'. Follow-up was censored on date of 167 transplant failure, death, loss to follow-up or last entry in the electronic patient 168 record, whichever was first. 
Results
198
There were 138 pregnancies to 89 transplant recipients reported between 199 1973 and 2013. Median duration of follow-up from first pregnancy was 8.2 200 years (IQR: 3.8, 16.9). Fifty-seven women had one pregnancy (64.0%), 22 201 had two pregnancies (24.7%), 7 had three pregnancies (7.9%) and 3 had four 202 pregnancies (3.4%). Four women had pregnancies with two different kidney 203
transplants. There was one triplet pregnancy. 204
One patient required temporary dialysis during pregnancy. Three women 205 conceived with a functioning transplant for most of their pregnancy but 206 returned to dialysis before delivery. Median time between transplantation and 207 pregnancy was 3.6 (IQR: 1.9, 7) years. Median RRT time pre-pregnancy was 208 6.9 (IQR: 3.8, 10.4) years (Table 1) . 209
210
Maternal demographics 211
Mean ages at time of transplantation and pregnancy were 25.2 (SD 6.4) and 212 30.3 (SD 5.1) years respectively. The most common primary kidney disease 213 was reflux nephropathy (48.3%), followed by glomerulonephritis (36.0%), 214 cystic disease (2.2%), diabetes (1.1%) and other/unknown (12.4%). 215
Approximately two-thirds of transplanted kidneys were from deceased donors 216 and 30 (21.7%) women had one previous kidney transplant. Mean systolic 217
and diastolic BP at conception was 126.9 (SD 16.6) and 80.5 (SD 9.8) mmHg. 218
Fifty-six (40.6%) women were on antihypertensive therapy before pregnancy. 219
Six women (4.3%) had an episode of acute rejection of the current transplant 220 before pregnancy (Table 1) . 
terminations. 239
Two women underwent in vitro fertilisation resulting in early miscarriage and 240
stillbirth. 241 242
Gestational age and mode of delivery 243
Median gestational age at delivery was 34.3 (IQR: 23.8, 37.4) weeks. Of 102 244 live births, 62 (60.8%) were preterm (<37 weeks). 5.9% of babies were born at 245
<32 weeks gestation. 246
Of the 102 live births, 22 (21.6%) were vaginal deliveries and 80 (78.4%) were 247 caesarean deliveries (43 elective, 32 emergency and 5 unknown). Seven 248 (11.3%) preterm births were vaginal deliveries and the remaining 55 (88.7%) 249
were caesarean deliveries (28 elective, 24 emergency and 3 unknown). 250 251
Birth weight 252
Six birth weights were missing. Mean birth weight of all newborns was 2464 253 (SD 727) g. Forty-one (45.1%) had low birth weight (<2500g), and 6 (6.6%) 254 had very low birth weight (<1500g). 255
Of 96 singleton pregnancies with gestational age and birth weight data, 13 256 (13.5%) and 9 (9.4%) had birth weights below the 10 th and 3 rd centile for 257 gestational age respectively. 
Transplant survival and function 287
Sixteen patients lost their transplant, 3 during pregnancy and a further 13 288 women within 2 years following delivery. Six women had biopsy-proven acute 289 rejection (BPAR) during pregnancy from which 2 lost their transplant. All 290 rejection episodes were treated with high dose oral or intravenous steroids 291 and a dose increase in the calcineurin inhibitor (or switch from cyclosporine to 292 tacrolimus). In 3 patients, tacrolimus or cyclosporine levels were deemed 293 subtherapeutic the period before the rejection episodes. 294
Pregnancy associated transplant dysfunction occurred in 38 (27.5%) 295 pregnancies including the women who returned to dialysis. Pre-pregnancy 296 (OR 1.86 for each additional 100mg/mmol; 95% CI, 1.11 to 3.10; p=0.02) at 316 conception as independent predictors of poor obstetric outcome (Table 3) . (Table 4) . Multivariable analysis did not demonstrate any 322 independent predictors of either obstetric or kidney outcomes (Tables 3, 4) . 323 324
Matched cohort study 325
Of 93 women with first pregnancy, 83 could be matched to non-pregnant renal 326 transplant controls. Baseline characteristics of pregnant women and non-327 pregnant controls are shown in Table 5 . There were no significant differences 328 between pregnant women who were matched and the 10 women who were 329 not matched. 330
Transplant function declined in both groups but there were no significant 331 differences in eGFR between pregnant women and non-pregnant controls at 332 'matching day', 1 year, 5 years or 10 years after the 'matching day' (Figure 2) . 333
Acute rejection episodes occurred in 5 pregnant women during the gestational 334 period and 2 non-pregnant controls during the corresponding time period, 335 respectively. By Kaplan Meier analysis, overall transplant survival was similar 336 for pregnant and control subjects (1-year transplant survival 98.8% vs. 98.8%, 337 5-year 75.9% vs. 81.1%, and 10-year 54.2% vs. 68.5%; p=0.79). Transplant 338 survival censored for death with functioning kidney was similar for pregnant 339 and control subjects (1-year death censored transplant survival 98.8% vs. 340 98.8%, 5-year 79.6% vs. 81.1%, and 10-year 59.8% vs. 69.8%; p=0.60) 341 ( Figure 3A) . There was no difference in patient survival between pregnant 342 women and non-pregnant controls (1-year survival 100% vs. 100%, 5-year 343 survival 95.5% vs. 100%, 10-year survival 88.1% vs. 98.1%, and 20-year 344 survival 88.1% vs. 72.0%; p=0.77) ( Figure 3B) . 345
346
Discussion
347
We report on 138 pregnancies in 89 transplant recipients over four decades. 348
To the best of our knowledge, this is the largest number of pregnancies 349
reported from a single centre with long-term follow-up and adequate controls 350 and the first one that uses pre-pregnancy eGFR instead of serum creatinine. The 74% live birth rate is similar to various registry reports(2, 5, 6, 13). Early 365 pregnancy losses (miscarriages and ectopic pregnancies) were more frequent 366 in our study (19% vs 
. 14%(8)). 367
Live birth rates did not change over four decades. Spontaneous miscarriage 368 and ectopic pregnancy rates increased from 13% in the 1970's to 36% after 369 2000 despite reduction in terminations. This may represent willingness to 370 support higher risk pregnancies in recent times or prior under-reporting of 371 early pregnancy losses. However, the mean eGFR prior to pregnancy did not 372 decline over the decades. 373
Renal impairment and proteinuria were associated with poor pregnancy 374 outcome, as reported previously (3, 14) . Historically, pre-pregnancy serum 375 creatinine of >1.5mg/dL predicts adverse pregnancy outcomes(5, 15, 16). We 376 used a pre-pregnancy eGFR cut-off of 45ml/min/1.73m 2 , which corresponds to 377 serum creatinine of 1.5mg/dL, and we showed that women with CKD stage 3B 378 or more advanced renal disease are at greater risk for small gestational age 379 and low birth weight. We found no relationship between deceased and live 380 This is the first study to report on a large number of multiple pregnancies with 388 the same transplant. Women who had multiple pregnancies had similar 389 obstetric and long-term kidney outcomes to women who had single 390
pregnancies. 391
Perinatal mortality among babies born to transplant recipients was 2.9% 392 compared to <1% in the general UK and US population and between 1% to 393
5.8% in women with transplants(2, 3, 19). 394
Incidence of birth defects in our cohort was similar to the general population of 395 3-5%. We do not have data on long-term developmental outcomes. In the case-cohort study there was no significant difference in eGFR at 1, 5 417 and 10 years after study entry between pregnant women and non-pregnant 418 controls; mean eGFR fell in both groups, however there was no difference in 419 transplant survival, death censored transplant survival or patient survival. The 420 immunosuppression regimens used in both groups were similar but as 421 expected more patients in the control group used mycophenolate mofetil. Our 422 data showed that 90% of mothers survive 20 years from first pregnancy to 423 raise the child to adulthood. However at the child's 10 th birthday, there is 424 approximately 40% chance that the mother's transplant will have failed. This 425 is useful information for physicians involved in pre-conception counselling. 426
We acknowledge this study has limitations. The analysis was retrospective 427 although data were retrieved mainly from prospectively maintained 428 comprehensive electronic records. Single centre studies have the advantage 429 of uniformity of therapeutic approach but treatments, including 430 immunosuppressive regimens, have changed substantially over this time 431 period. Therefore we analysed different eras but were unable to detect any 432 era effect. Single centre studies may lack generalisability but it is reassuring 433 that our outcomes compare with high-quality national data(2, 4) and a recent 434 meta-analysis(8). The number of cases available for study was higher than 435 previous single centre reports but the low rate of serious obstetric 436 complications means some analyses may be underpowered to detect 437 important associations. Under-reporting of early pregnancies is likely so we 438 can be less definitive about incidence of conception and early pregnancy 439 complications. Diagnostic criteria for renal transplant rejection have changed 440 over the era of this study, with the introduction of C4d staining and routine 441 testing for donor specific antibodies occurring only during the last 10 years of 442 this study. Therefore we cannot definitively exclude a component of antibody-443 mediated rejection in the patients who had episodes of rejection. 444
In this large single-centre study of pregnancy and kidney outcomes extending 
